Veronika Sexl (born February 27, 1966) is an Austrian pharmacologist and toxicologist with a research focus on cancer. Since March 1, 2023, she has served as rector of the University of Innsbruck. She has received several awards, including the City of Vienna Prize in the medicine category, the Novartis Prize for Medicine and the Alois Sonnleitner Prize, and the Cardinal Innitzer Award for Natural Sciences.
Sexl studied medicine in Vienna, then worked in Seattle and Memphis. [1] [2] She returned to Vienna in 2007 when she was appointed professor at the Medical University of Vienna. [1] She also served as Chair of the Senate of the Veterinary University of Vienna, and as Austria’s representative on the European Molecular Biology Organization (EMBL/EMBO). [3]
Her main research areas include comparative and translational medicine, using transgenic animals and human patient samples as disease models; NK cell–mediated tumor surveillance with a focus on leukemia; and signaling pathways involved in hematopoiesis and leukemogenesis, with an emphasis on JAK-STAT signaling and the novel role of CDK6 as a transcriptional regulator. [4]
In 2017, Sexl was awarded the City of Vienna Prize in the medicine category for “her outstanding performance during her career”. [5] She is a member of the Austrian Academy of Sciences. [1] She has also been awarded the Novartis Prize for Medicine and the Alois Sonnleitner Prize. [1] [6] In 2023, she was honoured with the Cardinal Innitzer Award for Natural Sciences “for her outstanding achievements in the field of cancer research”. [3]
In 2023, she was appointed rector of the University of Innsbruck. [3] [1] [7]
| International | |
|---|---|
| National | |
| Academics | |
